354 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer
Condition: Urinary Bladder Cancer
Intervention: Drug: Gemcitabine-Releasing Intravesical System (GemRIS)
22 Not yet recruiting Safety and Tolerability of GemRIS 225 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
Condition: Urinary Bladder Cancer
Intervention: Drug: Gemcitabine-Releasing Intravesical System (GemRIS)
23 Recruiting Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer
Conditions: Bladder Cancer;   Gemcitabine and Cisplatin Chemotherapy;   Epirubicin Instillation;   Recurrence;   Prognosis
Intervention: Drug: Gemcitabine, cisplatin
24 Not yet recruiting Radical Cystectomy Compared With Chemoradiation for Muscle Invasive Bladder Cancer
Condition: Muscle Invasive Bladder Cancer
Interventions: Radiation: Radiation and chemotherapy;   Procedure: Radical cystectomy
25 Recruiting The Feasibility of a Diet and Exercise Intervention in Diabetics During Treatment for Non-muscle Invasive Bladder Cancer
Conditions: Bladder Cancer;   Diabetes Mellitus
Interventions: Other: CR diet;   Behavioral: Exercise
26 Recruiting Trimodality Bladder Preservation Therapy: Maximal Transurethral Resection Followed by Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin (AMVAC) and Concurrent Chemoradiation With Intensity Modulated Radiation Therapy for Muscle Invasive Bladder Cancer
Condition: Urothelial Carcinoma of the Bladder
Interventions: Drug: Methotrexate;   Drug: Vinblastine;   Drug: Doxorubicin;   Drug: Cisplatin;   Radiation: Intensity modulated radiation therapy;   Procedure: Maximal Transurethral Resection;   Drug: 5-FU;   Drug: Mitomycin C
27 Recruiting Genetic Predictors of Benefit to Pembrolizumab
Conditions: Carcinoma, Non-Small-Cell Lung;   Cancer of the Head and Neck;   Urinary Bladder Neoplasms;   Esophageal Squamous Cell Carcinoma;   Carcinoma, Transitional Cell
Intervention: Drug: Pembrolizumab
28 Not yet recruiting Urinary Biomarkers in Overactive Bladder in Children
Condition: Overactive Bladder
Intervention: Drug: Oxybutynin
29 Not yet recruiting Observation Versus Immediate Surgery of Low Risk Bladder Cancer
Condition: Bladder Cancer
Interventions: Other: Immediate Surgery;   Other: Observation;   Procedure: Surveillance Cystoscopy and Urinary Cytology
30 Not yet recruiting Robotic or Open Radical Cystectomy in Treating Patients With Bladder Cancer
Conditions: Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma
Interventions: Other: Questionnaire Administration;   Procedure: Radical Cystectomy
31 Not yet recruiting Antiseptic-coated Intermittent Urinary Catheter
Conditions: Neurogenic Bladder;   Catheter-Related Infections
Interventions: Device: Antiseptic-coated catheter;   Device: Hydrophilic catheter;   Drug: Octenidine chloride
32 Recruiting Ultrasound-Guided ONB for Transurethral Procedures - Interadductor Approach
Conditions: Urinary Bladder Neoplasms;   Transurethral Resection;   Nerve Block
Interventions: Device: Ultrasound;   Drug: lidocaine 2%;   Drug: 0.9% Natrium Chloratum with a 2nd generation cephalosporin
33 Not yet recruiting The Bladder Instillation Comparison Study
Condition: Urinary Bladder Neoplasms
Interventions: Drug: Mitomycin C;   Drug: Gemcitabine
34 Not yet recruiting A Trial to Evaluate Pemetrexed Clinical Responses in Relation to Tumor MTAP Gene Status in Patients With Previously Treated Metastatic Urothelial Carcinoma
Conditions: Bladder Cancer;   Urothelial Cancer
Interventions: Drug: Pemetrexed;   Dietary Supplement: Folic Acid;   Dietary Supplement: Vitamin B12;   Drug: Dexamethasone
35 Not yet recruiting Phase 2 Study of Pembrolizumab in Combination With Gemcitabine and Cisplatin as Neoadjuvant Therapy
Condition: Bladder Cancer
Intervention: Drug: pembrolizumab, gemcitabine and cisplatin
36 Recruiting Anterior Pelvic Prolapse Reconstruction With TiLOOP® PRO A Polypropylene Mesh
Conditions: Cystocele;   Uterine Prolapse
Intervention: Device: TiLOOP® PRO A (surgical mesh implant)
37 Not yet recruiting Quality of Life After Bladder-Preservation Chemotherapy and Radiation Therapy in Patients With Muscle-Invasive Bladder Cancer
Condition: Infiltrating Bladder Urothelial Carcinoma
Interventions: Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
38 Not yet recruiting Detecting Bladder Cancer Using the UroMark Test.
Condition: Bladder Cancer
Intervention: Other: Group
39 Not yet recruiting Safety and Efficacy Study of Intravesical Instillations of BotuGelTM, Slow Release RTGel Based Botox® Formulations, in Idiopathic OAB Patients With Urinary Incontinence ("INTIMO2")
Condition: Overactive Bladder
Interventions: Drug: 300 IU of BotuGelTM (60ml);   Drug: 400 IU of BotuGelTM (60ml);   Device: TC-3 Gel
40 Not yet recruiting Observational Study of Botulinum Toxin Type A in Patients With Urinary Incontinence Associated With Overactive Bladder
Conditions: Urinary Bladder, Overactive;   Urinary Bladder, Neurogenic
Intervention: Biological: botulinum toxin Type A

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years